Formulation and Characterization of Mesoporous Nanoparticulate Drug Delivery Platform

Authors

  • Suraj S. Patil KYDSCT’s College of Pharmacy, Sakegaon, Bhusawal, Maharashtra, India
  • P.K. Deshmukh HR Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Maharashtra, India
  • R.L. Bakal KYDSCT’s College of Pharmacy, Sakegaon, Bhusawal, Maharashtra, India
  • C.R. Rakhunde KYDSCT’s College of Pharmacy, Sakegaon, Bhusawal, Maharashtra, India
  • R.G. Jadhao KYDSCT’s College of Pharmacy, Sakegaon, Bhusawal, Maharashtra, India

DOI:

https://doi.org/10.37591/tdd.v2i1.273

Abstract

The aim of this study was to synthesize and characterize mesoporous silica nanoparticles, namely, SBA-15 (Santa Barbara Amorphous) and MCM-41 (Mobile Crystalline Material) as a drug delivery platform. These MSNs have been synthesized using triblock copolymer F 127, cetyl trimethyl ammonium bromide (CTAB) as a co-surfactant and tetraethyl orthosilicate (TEOS) as a silica precursor. The synthesized MSNs were characterized by scanning electron microscopy (SEM), powder X-ray diffraction (PXRD), particle size and surface area analysis (BET analysis), differential scanning calorimetry (DSC), in vitro dissolution test, and solubility study. The loading efficiency was assessed by incorporating the DCN (Diacerein) via passive loading and it was estimated to be 28%. Synthesized MSN, i.e., SBA-15 and MCM-41 were mean particle sizes of 650 and 450 nm and specific area 1111.44 and 250.20, respectively. The result reveals synthesized MSN with small particle size and high surface area. The drug release will help in the design of drug delivery system for the dissolution enhancement of water-insoluble drugs.

 

Keywords: Diacerein, mesoporous silica nanoparticles, triblock copolymer, SBA-15, MCM-41

Cite this Article

Patil Suraj S, Deshmukh PK, Bakal RL, et al. Formulation and characterization of mesoporous nanoparticulate drug delivery platform. Trends in Drug Delivery. 2015; 2(1): 21–27p

Downloads

Published

2019-02-21

Issue

Vol. 2 No. 1 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.